Saturday 31 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

62.55 1.16 +1.89%

Follow BMY

Alert me

Market cap: $125.4B
P/E: 13.8×
Fwd P/E: 11.9×
Dividend yield: 4.03%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Earnings & Analysis Segments Filings

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	33.74%	40.43%	38.75%	46.63%
Piotroski F-Score Full definition →		7	8	7	7
ROA Full definition →		6.34%	7.72%	8.13%	10.18%
ROIC Full definition →		9.83%	11.01%	11.09%	13.69%
Return on Tangible Assets Full definition →		40.69%	52.19%	46.31%	52.41%
Average Days of Receivables Full definition →		86.79	86.44	70.53	78.31
Free Cash Flow per Share Full definition →		7.52	6.32	5.84	5.60
Free Cash Flow Full definition →		15,302.00	12,845.00	11,908.00	11,440.00
Capital Expenditures Full definition →		(1,319.00)	(1,311.00)	(1,398.00)	(1,342.00)
Other line items
Cash ROIC Full definition →		18.20%	17.29%	15.87%	14.95%
Accounts Receivable Turnover Full definition →		4.28	4.35	4.81	4.48
Accounts Payable Turnover Full definition →		3.78	3.88	3.48	3.06
Inventory Turnover Full definition →		4.81	5.31	5.28	5.36
Average Days of Payables Full definition →		106.82	93.63	107.89	103.40
Days of Inventory on Hand Full definition →		68.71	70.45	70.23	68.06
Tax Rate Full definition →		(0.25)	(0.24)	(0.24)	(0.22)
Research and Development Expense of Revenue Full definition →		21.98%	20.65%	21.33%	21.80%
Selling, General and Administrative Expense of Revenue Full definition →		15.04%	15.08%	15.06%	15.07%
Share Based Compensation of Revenue Full definition →		1.12%	1.15%	1.14%	1.12%
Operating CF/Net income Full definition →		2.75	2.01	1.83	1.38
Depreciation/Fixed assets Full definition →		0.67	0.53	0.47	0.41
Capex/Depreciation Full definition →		(0.27)	(0.33)	(0.39)	(0.42)
Revenue per Share Full definition →		23.59	23.69	23.79	24.09
Operating CF per Share Full definition →		8.16	6.96	6.53	6.26
Capex per Share Full definition →		(0.65)	(0.64)	(0.69)	(0.66)
Capex to Sales Full definition →		0.03	0.03	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly